BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18978139)

  • 1. Pathomechanisms of cyst formation in pulmonary light chain deposition disease.
    Colombat M; Caudroy S; Lagonotte E; Mal H; Danel C; Stern M; Fournier M; Birembaut P
    Eur Respir J; 2008 Nov; 32(5):1399-403. PubMed ID: 18978139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic lung disease.
    Clarke BE
    J Clin Pathol; 2013 Oct; 66(10):904-8. PubMed ID: 23729207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis.
    Hayashi T; Rush WL; Travis WD; Liotta LA; Stetler-Stevenson WG; Ferrans VJ
    Arch Pathol Lab Med; 1997 Sep; 121(9):930-7. PubMed ID: 9302924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
    Merrilees MJ; Hankin EJ; Black JL; Beaumont B
    J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangioleiomyomatosis and Other Cystic Lung Diseases.
    Koslow M; Lynch DA; Cool CD; Groshong SD; Downey GP
    Immunol Allergy Clin North Am; 2023 May; 43(2):359-377. PubMed ID: 37055093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary light chain deposition disease: report of five cases and review of the literature.
    Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
    Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary cystic disorder related to light chain deposition disease.
    Colombat M; Stern M; Groussard O; Droz D; Brauner M; Valeyre D; Mal H; Taillé C; Monnet I; Fournier M; Herson S; Danel C
    Am J Respir Crit Care Med; 2006 Apr; 173(7):777-80. PubMed ID: 16399989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.
    Colombat M; Mal H; Copie-Bergman C; Diebold J; Damotte D; Callard P; Fournier M; Farcet JP; Stern M; Delfau-Larue MH
    Blood; 2008 Sep; 112(5):2004-12. PubMed ID: 18483396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung transplantation for advanced cystic lung disease due to nonamyloid kappa light chain deposits.
    Hirschi S; Colombat M; Kessler R; Reynaud-Gaubert M; Stern M; Chenard MP; MĂ©tivier AC; Jeung MY; Mal H
    Ann Am Thorac Soc; 2014 Sep; 11(7):1025-31. PubMed ID: 25118847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis of cystic lung diseases: a role for bronchoalveolar lavage and transbronchial biopsy?
    Torre O; Harari S
    Respir Med; 2010 Jul; 104 Suppl 1():S81-5. PubMed ID: 20430602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary manifestations of light chain deposition disease.
    Rho L; Qiu L; Strauchen JA; Gordon RE; Teirstein AS
    Respirology; 2009 Jul; 14(5):767-70. PubMed ID: 19659654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes and outcome of diffuse pulmonary non-amyloid light chain deposition disease.
    Lestelle F; Beigelman C; Rotzinger D; Si-Mohamed S; Nasser M; Wemeau L; Hirschi S; Prevot G; Roux A; Bunel V; Gomez E; Sohier L; Pradier HM; Gaubert MR; Gondouin A; Lazor R; Glerant JC; Bejui FT; Colombat M; Cottin V;
    Respir Res; 2024 Apr; 25(1):159. PubMed ID: 38600600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic interstitial lung diseases: recognizing the common and uncommon entities.
    Jawad H; Walker CM; Wu CC; Chung JH
    Curr Probl Diagn Radiol; 2014; 43(3):115-27. PubMed ID: 24791615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult pulmonary Langerhans' cell histiocytosis.
    Tazi A
    Eur Respir J; 2006 Jun; 27(6):1272-85. PubMed ID: 16772390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases in blood from patients with LAM.
    Odajima N; Betsuyaku T; Nasuhara Y; Inoue H; Seyama K; Nishimura M
    Respir Med; 2009 Jan; 103(1):124-9. PubMed ID: 18760908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis.
    Kambouchner M; Basset F; Marchal J; Uhl JF; Hance AJ; Soler P
    Am J Respir Crit Care Med; 2002 Dec; 166(11):1483-90. PubMed ID: 12450935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X).
    Fukuda Y; Basset F; Soler P; Ferrans VJ; Masugi Y; Crystal RG
    Am J Pathol; 1990 Aug; 137(2):415-24. PubMed ID: 2386203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An unusual cause of cystic lung disease: light chain deposition disease].
    Luraine R; Sohier L; Kerjouan M; Desrues B; Delaval P; Jouneau S
    Rev Mal Respir; 2013 Sep; 30(7):567-71. PubMed ID: 24034462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
    Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q
    Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption.
    Weiler C; Nerlich AG; Zipperer J; Bachmeier BE; Boos N
    Eur Spine J; 2002 Aug; 11(4):308-20. PubMed ID: 12193991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.